2-(Benzyloxy)cyclobutan-1-one: Properties, Synthesis & Applications

2-(benzyloxy)cyclobutan-1-one is a strained four-membered carbocyclic ketone bearing a benzyloxy substituent at the alpha position, making it a highly versatile intermediate for stereoselective synthesis and ring-expansion chemistry.

IUPAC Name

2-(benzyloxy)cyclobutan-1-one

Molecular Formula

C₁₁H₁₂O₂

Molecular Weight

176.21 g/mol

Core Structural Feature

Four-membered cyclobutanone ring with alpha-benzyloxy group

Key Reactivity

Ring-strain-driven ring opening, nucleophilic addition to ketone, and Baeyer-Villiger oxidation

Protecting Group Strategy

Benzyl ether is removable by hydrogenolysis (Pd/C, H₂)

Chemical Structure and Physical Properties

2-(Benzyloxy)cyclobutan-1-one (SKU: B175666) consists of a cyclobutanone scaffold — a four-membered ring ketone — with a benzyloxy (–OCH₂Ph) substituent at the C-2 (alpha) position. The molecular formula is C₁₁H₁₂O₂, giving a molecular weight of 176.21 g/mol. The compound belongs to the broader class of alpha-oxy ketones and combines two pharmacophoric elements in a compact chiral-ready framework: the electrophilic carbonyl and the oxygen-linked benzyl protecting group.

The cyclobutanone ring imparts approximately 26 kcal/mol of ring strain (Baeyer strain), which significantly elevates the reactivity of the carbonyl toward nucleophiles compared with open-chain or six-membered ring analogs. The sp³ alpha carbon bearing the benzyloxy group is also adjacent to the carbonyl, making it susceptible to enolization and further functionalization. The benzyl ether oxygen lone pairs participate in hyperconjugation with the ring, influencing the conformational landscape and facial selectivity in asymmetric reactions.

Synthesis and Preparation Routes

The most common synthetic approach to 2-(benzyloxy)cyclobutan-1-one involves alpha-oxygenation of cyclobutanone. A general two-step sequence begins with the generation of the cyclobutanone enolate — typically using a hindered base such as LDA (lithium diisopropylamide) at low temperature — followed by electrophilic benzylation of the resulting enolate with benzyl bromide (BnBr) in the presence of a suitable base, or alternatively via O-benzylation of the corresponding alpha-hydroxy cyclobutanone intermediate.

An alternative route proceeds through [2+2] cycloaddition strategies to build the cyclobutanone core, followed by selective functionalization of the ring to introduce the alpha-oxy group. Oxidative methods, including alpha-hydroxylation of cyclobutanone enolates using Davis oxaziridine or Rubottom-type oxidation followed by benzyl protection, also afford the target compound with defined stereochemistry when chiral auxiliaries or asymmetric catalysts are employed.

Careful control of reaction temperature (typically −78 °C for enolization steps) and the choice of solvent (THF or DME) are critical for minimizing di-alkylation and ensuring high regioselectivity at the alpha position.

Research Applications in Organic and Medicinal Chemistry

2-(Benzyloxy)cyclobutan-1-one is valued as a multifunctional synthetic building block primarily because cyclobutanone derivatives are pivotal scaffolds in both total synthesis and medicinal chemistry. The inherent ring strain makes the compound an excellent partner in ring-expansion reactions: treatment with diazomethane or Baeyer-Villiger oxidation conditions allows conversion to five- or six-membered lactone/ring-expanded products while retaining the encoded stereocenters.

The alpha-benzyloxy substituent serves simultaneously as a hydroxyl surrogate and a handle for further elaboration after deprotection. Hydrogenolysis (Pd/C, H₂) cleanly removes the benzyl group to reveal a free alpha-hydroxy cyclobutanone, which can serve as a chiral pool intermediate toward natural product synthesis, beta-lactam chemistry, or access to cyclobutane-containing drug scaffolds. Recent medicinal chemistry programs have highlighted the value of small, strained carbocycles — including cyclobutanes and cyclobutanones — as bioisosteres for gem-dimethyl groups or aromatic rings, improving metabolic stability and aqueous solubility of drug candidates.

The compound is also applicable in asymmetric aldol reactions, Mannich-type condensations, and as a substrate for organocatalytic alpha-functionalization to build molecular complexity with high enantioselectivity.

Handling, Storage, and Safety Considerations

As with most alpha-oxy ketone reagents, 2-(benzyloxy)cyclobutan-1-one should be handled in a well-ventilated fume hood using standard personal protective equipment, including nitrile gloves, safety glasses, and a laboratory coat. The compound is not classified as acutely toxic under routine handling conditions, but prolonged skin or eye contact should be avoided and appropriate safety data sheet (SDS) guidelines followed.

Storage is recommended in a cool, dry, dark environment — ideally at 2–8 °C under an inert atmosphere (nitrogen or argon) to prevent oxidation of the alpha-oxy functionality and potential degradation of the benzyl ether under strongly acidic or strongly oxidizing conditions. Ensure the container is tightly sealed between uses. The compound should be kept away from strong oxidizing agents, strong bases, and Lewis acids that could promote unwanted ring-opening or ether cleavage.

Researchers should consult the product-specific SDS provided by Aladdin Scientific (SKU: B175666) for complete hazard classification, first-aid measures, and disposal procedures compliant with local regulations.

Frequently asked questions

What makes 2-(benzyloxy)cyclobutan-1-one useful as a synthetic building block?

The compound combines the high reactivity of a strained cyclobutanone carbonyl with the versatility of a benzyloxy protecting group at the alpha position. This dual functionality allows it to participate in ring-expansion reactions, nucleophilic additions, and asymmetric transformations, while the benzyl group can be cleanly removed by hydrogenolysis to unmask a free hydroxyl group for further chemistry.

How should 2-(benzyloxy)cyclobutan-1-one be stored to maintain stability?

The compound should be stored at 2–8 °C in a tightly sealed container under an inert atmosphere (nitrogen or argon), away from light, moisture, strong oxidizing agents, and strong acids or bases. These conditions minimize potential degradation of the alpha-oxy functionality and the benzyl ether linkage.

Can the benzyl protecting group in 2-(benzyloxy)cyclobutan-1-one be selectively removed?

Yes. The benzyl ether is typically removed cleanly by catalytic hydrogenolysis using palladium on carbon (Pd/C) under a hydrogen atmosphere in a protic solvent such as ethanol or methanol. This mild and selective method affords the corresponding free alpha-hydroxy cyclobutanone without disturbing the cyclobutanone ring or other sensitive functional groups.

What ring-expansion reactions are accessible from 2-(benzyloxy)cyclobutan-1-one?

The strained cyclobutanone ring is susceptible to Baeyer-Villiger oxidation (using peracids such as mCPBA) to give the corresponding five-membered beta-lactone or, under homologation conditions with diazomethane, to afford a cyclopentanone. These ring-expansion pathways are valuable for constructing medium-ring and five-membered ring-containing natural product frameworks.

References

1. Clayden, J.; Greeves, N.; Warren, S. Organic Chemistry, 2nd ed.; Oxford University Press: Oxford, 2012. (General reference on cyclobutanone reactivity and ring-strain chemistry.)
2. Illuminati, G.; Mandolini, L. Ring closure reactions of bifunctional chain molecules. Acc. Chem. Res. 1981, 14, 95–102. (Ring-strain and small-ring reactivity reference.) doi:10.1021/ar00063a004
3. Rhoads, S. J.; Raulins, N. R. The Cope and Claisen rearrangements. Org. React. 1975, 22, 1–252. (General strained-ring rearrangement background.)
4. Lovering, F.; Bikker, J.; Humblet, C. Escape from flatland: increasing saturation as an approach to improving clinical success. J. Med. Chem. 2009, 52, 6752–6756. (Medicinal chemistry rationale for strained carbocycles as drug scaffolds.) doi:10.1021/jm901241e

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.